HIV treatment Dovato (dolutegravir/lamivudine) approved in Japan

08:15 EST 15 Jan 2020 | European Pharmaceutical Review

The Japanese Ministry of Health, Labour and Welfare (#MHLW) has granted marketing approval for Dovato, a treatment for HIV-1 infection.

The post HIV treatment Dovato (dolutegravir/lamivudine) approved in Japan appeared first on European Pharmaceutical Review.

Original Article: HIV treatment Dovato (dolutegravir/lamivudine) approved in Japan


More From BioPortfolio on "HIV treatment Dovato (dolutegravir/lamivudine) approved in Japan"

Quick Search

Relevant Topics

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...